| Jeffrey M Geitz, MD | |
|
511 S Santa Fe Ave, Salina, KS 67401-4145 | |
| (785) 452-4860 | |
| (785) 452-4878 |
| Full Name | Jeffrey M Geitz |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 18 Years |
| Location | 511 S Santa Fe Ave, Salina, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124246855 | NPI | - | NPPES |
| 200613380C | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 04-32987 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Salina Regional Health Center | Salina, KS | Hospital |
| Memorial Hospital | Abilene, KS | Hospital |
| Cloud County Health Center | Concordia, KS | Hospital |
| Ellsworth County Medical Center | Ellsworth, KS | Hospital |
| Republic County Hospital | Belleville, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Salina Regional Health Center Inc | 0446168215 | 138 |
News Archive
Women who have IVF/ICSI infertility treatments have a 29% chance of conceiving naturally within six years of the cessation of treatments. These are the findings of an Internet survey conducted by a group of gynaecologists presented in the journal Human Fertility.
The Food and Drug Administration has approved the drug fampridine-SR for the treatment of multiple sclerosis. Researchers at the University of Rochester Medical Center (URMC) have been evaluating the effects of the drug in MS for more than 10 years- it is the first medication shown to enhance some neurological functions in people with the disease - and their efforts helped pave the way for today's action by the FDA.
According to a new review, approximately 30 million Americans – about 15 percent of adults – have chronic kidney disease, a number that is expected to increase in the next 20 years due to rising obesity rates and longer lifespans, but the majority of chronic kidney disease patients aren't receiving potentially lifesaving treatment.
Cancer patients could one day experience fewer side effects from chemotherapy following a discovery that opens the door for more targeted treatments.
› Verified 7 days ago
| Entity Name | Salina Regional Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619952785 PECOS PAC ID: 0446168215 Enrollment ID: O20040130000800 |
News Archive
Women who have IVF/ICSI infertility treatments have a 29% chance of conceiving naturally within six years of the cessation of treatments. These are the findings of an Internet survey conducted by a group of gynaecologists presented in the journal Human Fertility.
The Food and Drug Administration has approved the drug fampridine-SR for the treatment of multiple sclerosis. Researchers at the University of Rochester Medical Center (URMC) have been evaluating the effects of the drug in MS for more than 10 years- it is the first medication shown to enhance some neurological functions in people with the disease - and their efforts helped pave the way for today's action by the FDA.
According to a new review, approximately 30 million Americans – about 15 percent of adults – have chronic kidney disease, a number that is expected to increase in the next 20 years due to rising obesity rates and longer lifespans, but the majority of chronic kidney disease patients aren't receiving potentially lifesaving treatment.
Cancer patients could one day experience fewer side effects from chemotherapy following a discovery that opens the door for more targeted treatments.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey M Geitz, MD 511 S Santa Fe Ave, Salina, KS 67401-4145 Ph: (785) 452-7269 | Jeffrey M Geitz, MD 511 S Santa Fe Ave, Salina, KS 67401-4145 Ph: (785) 452-4860 |
News Archive
Women who have IVF/ICSI infertility treatments have a 29% chance of conceiving naturally within six years of the cessation of treatments. These are the findings of an Internet survey conducted by a group of gynaecologists presented in the journal Human Fertility.
The Food and Drug Administration has approved the drug fampridine-SR for the treatment of multiple sclerosis. Researchers at the University of Rochester Medical Center (URMC) have been evaluating the effects of the drug in MS for more than 10 years- it is the first medication shown to enhance some neurological functions in people with the disease - and their efforts helped pave the way for today's action by the FDA.
According to a new review, approximately 30 million Americans – about 15 percent of adults – have chronic kidney disease, a number that is expected to increase in the next 20 years due to rising obesity rates and longer lifespans, but the majority of chronic kidney disease patients aren't receiving potentially lifesaving treatment.
Cancer patients could one day experience fewer side effects from chemotherapy following a discovery that opens the door for more targeted treatments.
› Verified 7 days ago
Dr. William F Cathcart-rake, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 511 S Santa Fe Ave, Salina, KS 67401 Phone: 785-827-7261 | |
Peeran D. Sandhu, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 511 S Santa Fe Ave, Suite 200, Salina, KS 67401 Phone: 785-452-4860 Fax: 785-452-4878 | |
Dr. William R Alsop, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 737 E Crawford St, Salina, KS 67401 Phone: 785-827-7261 | |
Dr. Carolyn Annette Hofer, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1410 E Iron Ave, Suite 1, Salina, KS 67401 Phone: 785-826-1580 | |
Dr. Kent B. Berquist, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 520 S Santa Fe Ave, Suite 120, Salina, KS 67401 Phone: 785-452-7325 Fax: 785-452-6570 | |
Dr. Michael K. Lawrence, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 501 S Santa Fe Ave, Suite 200, Salina, KS 67401 Phone: 785-452-7269 Fax: 785-452-7566 |